NDC Active Ingredient Acalabrutinib

Active Ingredient Information

What is the usage for Acalabrutinib?

This medication is used to treat certain types of cancer (such as mantle cell lymphoma, small lymphocytic lymphoma - SLL, chronic lymphocytic leukemia - CLL). Acalabrutinib works by slowing or stopping the growth of cancer cells. It belongs to a class of drugs known as kinase inhibitors.

How many products in the NDC database contain Acalabrutinib?

The NDC database has 6 products with the active ingredient Acalabrutinib. The following table lists all the products that have this active ingredient.

NDC Products with Acalabrutinib

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0310-0512Proprietary Name: Calquence AcalabrutinibCapsule, Gelatin CoatedOralAstrazeneca Pharmaceuticals LpACTIVE
0310-3512Proprietary Name: Calquence AcalabrutinibTablet, Film CoatedOralAstrazeneca Pharmaceuticals LpACTIVE
17228-0512Proprietary Name: AcalabrutinibCapsuleAstrazeneca AbACTIVE
54893-0108Proprietary Name: AcalabrutinibPowderMsn Laboratories Private LimitedACTIVE
60440-0512Proprietary Name: AcalabrutinibPowderAstrazeneca Uk LimitedACTIVE
86184-001Proprietary Name: AcalabrutinibPowderMaeda IncACTIVE